Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8713268 | Journal of Allergy and Clinical Immunology | 2018 | 35 Pages |
Abstract
When compared with placebo, γT supplementation for 14 days reduced inflammatory features of asthma, including sputum eosinophils and mucins, as well as acute airway response to inhaled LPS challenge. Larger scale clinical trials are needed to assess the efficacy of γT supplements as a complementary or steroid-sparing treatment for asthma.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Allison J. MD, Charity G. PhD, Yinghao MS, Patricia RN, Susan RN, Qing PhD, Chao MPhil, Sha'Leema BA, Heather BS, Neil PhD, Mehmet PhD, William D. PhD, Haibo PhD, David B. MD, MS, Michelle L. MD,